QNCX
#4408
Quince Therapeutics, Inc. - Common Stock
32.5 1 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.18%
Variación mensual
+35.80%
Variación en los últimos 6 meses
+29454.55%
Cambio anual
+1894.48%
Cierres anteriores
32.5 7
Open
33.1 6
Mínimo
32.5 1
Máximo
33.1 6
Volumen
4
Financials
- Market Capitalization 33.06 M
- Employee 38
- Founded 2012
- CEO N/A
- Website www.quincetx.com
- Headquarter California, United States
- FIGI BBG00BTK1DT8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.12
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4395 |  LITS Lite Strategy, Inc. - Common Stock | 1.01 USD | +2.02% | -3.81% | +4.12% | -66.11% | 34.37 M USD | ||
| 4397 |  CNTX Context Therapeutics Inc. - Common Stock | 0.37 USD | -5.13% | -17.78% | -40.32% | -56.47% | 34.00 M USD | ||
| 4424 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.01 USD | -0.98% | -7.34% | +18.82% | -2.88% | 31.76 M USD | ||
| 4425 |  KYNB Kyntra Bio, Inc. - Common Stock | 7.81 USD | +0.39% | +0.39% | +13.52% | -17.88% | 31.62 M USD |